| D-02 Oliver Sander Model-based development of the secukinumab dosing regimen for the treatment of moderate-to-severe chronic plaque psoriasis Friday 09:20-09:40 |
| D-02 Oliver Sander Model-based development of the secukinumab dosing regimen for the treatment of moderate-to-severe chronic plaque psoriasis Friday 09:20-09:40 |